메뉴 건너뛰기
Current Diabetes Reports
Volumn 7, Issue 1, 2007, Pages 53-55
The DREAM trial: Using ramipril and rosiglitazone to prevent diabetes

(2)  Shah, Viral a   Pratley, Richard E a  

a NONE
Author keywords

Acarbose; Impaired Fasting Glucose; Impaired Glucose Tolerance; Ramipril; Rosiglitazone
Indexed keywords

EID: 34247577093     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-007-0009-3     Document Type: Note
Times cited : (2)
References (12)
  • 1
    • 0043244907 scopus 로고    scopus 로고
    • American Diabetes Association: economic costs of diabetes in the U.S. in 2002
    • PID: 12610059
    • Hogan P, Dall T, Nikolov P; American Diabetes Association: economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003, 26:917–932. DOI: 10.2337/diacare.26.3.917
    • (2003) Diabetes Care , vol.26 , pp. 917-932
    • Hogan, P.1    Dall, T.2    Nikolov, P.3
  • 2
    • 0030935652 scopus 로고    scopus 로고
    • Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study
    • PID: 9096977, COI: 1:STN:280:ByiB2M7ivFE%3D
    • Pan X, Li G, Hu Y, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537–544. DOI: 10.2337/diacare.20.4.537
    • (1997) Diabetes Care , vol.20 , pp. 537-544
    • Pan, X.1    Li, G.2    Hu, Y.3
  • 3
    • 0035799806 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • PID: 11333990, COI: 1:STN:280:DC%2BD3M3kvFejsA%3D%3D
    • Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350. DOI: 10.1056/NEJM200105033441801
    • (2001) N Engl J Med , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1    Lindstrom, J.2    Eriksson, J.G.3
  • 4
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle or metformin
    • Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle or metformin. N Engl J Med 2002, 345:393–403.
    • (2002) N Engl J Med , vol.345 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3
  • 5
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial
    • PID: 12086760, COI: 1:CAS:528:DC%2BD38XkslGhs7g%3D
    • Chiasson JL, Josse RG, Gomis R, et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002, 359:2072–2077. DOI: 10.1016/S0140-6736(02)08905-5
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3
  • 6
    • 1042303480 scopus 로고    scopus 로고
    • XENical in the prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
    • PID: 14693982, COI: 1:CAS:528:DC%2BD2cXmvV2jug%3D%3D
    • Torgerson JS, Hauptman J, Boldrin MN, et al.: XENical in the prevention of Diabetes in Obese Subjects (XENDOS) Study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27:155–161. DOI: 10.2337/diacare.27.1.155
    • (2004) Diabetes Care , vol.27 , pp. 155-161
    • Torgerson, J.S.1    Hauptman, J.2    Boldrin, M.N.3
  • 7
    • 15944395414 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program
    • PID: 15793255
    • Knowler WC, Hamman RF, Edelstein SL, et al.: Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 2005, 54:1150–1156. DOI: 10.2337/diabetes.54.4.1150
    • (2005) Diabetes , vol.54 , pp. 1150-1156
    • Knowler, W.C.1    Hamman, R.F.2    Edelstein, S.L.3
  • 8
    • 0034032581 scopus 로고    scopus 로고
    • Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes
    • Buchanan TA, Xiang AH, Peters RK, et al.: Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 2000, 40:782–788. DOI: 10.2337/diabetes.49.5.782
    • (2000) Diabetes , vol.40 , pp. 782-788
    • Buchanan, T.A.1    Xiang, A.H.2    Peters, R.K.3
  • 9
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
    • PID: 10639539, COI: 1:STN:280:DC%2BD3c%2Fpt1emug%3D%3D
    • Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145–153. DOI: 10.1056/NEJM200001203420301
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3
  • 10
    • 33749609289 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitors for impaired glucose tolerance—is there still hope?
    • PID: 16980381, COI: 1:CAS:528:DC%2BD28XhtVyht7nL
    • Ingelfinger JR, Solomon CG, et al.: Angiotensin-converting enzyme inhibitors for impaired glucose tolerance—is there still hope? N Engl J Med 2006, 355:1608–1610. DOI: 10.1056/NEJMe068213
    • (2006) N Engl J Med , vol.355 , pp. 1608-1610
    • Ingelfinger, J.R.1    Solomon, C.G.2
  • 11
    • 3142781955 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system
    • COI: 1:CAS:528:DC%2BD2MXhs1Omuw%3D%3D
    • Scheen AJ, et al.: Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system. Drugs 2004, 64:2 537–2 565. DOI: 10.2165/00003495-200464220-00004
    • (2004) Drugs , vol.64 , pp. 2 537-2 565
    • Scheen, A.J.1
  • 12
    • 5644250670 scopus 로고    scopus 로고
    • Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial
    • PID: 15322749, COI: 1:STN:280:DC%2BD2cros1OjsA%3D%3D
    • Gerstein HC, Yusuf S, Holman R, et al.: Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 2004, 47:1519–1527. DOI: 10.1007/s00125-004-1485-5
    • (2004) Diabetologia , vol.47 , pp. 1519-1527
    • Gerstein, H.C.1    Yusuf, S.2    Holman, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.